News Nov 02, 2009
Key aspects of the agreement between the CDU, CSU and FDP are an endorsement of the cultivation of genetically modified Amflora starch potatoes, flexible, regionally determined minimum distances between fields with genetically modified crops and fields with conventional crops, and positive ‘GM-free’ labelling at European level. As far as the German cultivation ban on MON810 maize is concerned, the coalition intends to await the outcome of the ongoing court case.
The coalition partners want to change the Genetic Engineering Act to allow the federal states to set their own minimum separation distances between fields with genetically modified plants and fields with organic or conventional crops. The idea is to draw up a nationwide framework, although this is not defined in any more detail, so it is not yet clear whether such minimum distances will have to be based on scientific criteria in future.
The reaction of groups and associations to the agreements has been mixed. Germany’s organic food industry association (BÖLW) has severely criticised the agreements on plant biotechnology contained in the coalition agreement, saying it was "unbelievable" that a specific product produced by one company was mentioned in the agreement (the genetically modified Amflora potato). Greenpeace sees the agreement as evidence that the interests of corporations "clearly come before protection of the environment and people".
By contrast, the German Raiffeisen Association, an umbrella organisation that represents the interests of cooperatives in the German food and agriculture sector, welcomed the fact that the agreements promote the potential of plant biotechnology as an industry of the future. It claimed that this would make an important contribution to freedom of choice. What was needed now was to implement a legal framework in Germany and Europe that would prevent distortion of competition and would, in particular, make it feasible to work with European Community Law’s zero tolerance for GMOs not authorised in the EU.
Giant Viruses Invent Their Own GenesNews
Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.
Therapeutic CRISPR Could Be Cancer RiskNews
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study. Researchers say that more studies are required in order to guarantee the safety of these ‘molecular scissors’ for gene-editing therapies.
Who Owns the Ocean? One Company Has Registered Half of All Marine Gene PatentsNews
A single corporation has registered nearly half of all existing patents associated with genes from marine organisms, according to a new study. Researchers from the University of British Columbia and the Stockholm Resilience Centre examined the patents associated with marine species and found that BASF, the world’s largest chemical manufacturer, has registered 47 per cent of the 12,998 genetic sequences from 862 marine species.